SmartBreast™ Acquires Molecular Breast Imaging Assets from Dilon Technologies®
SmartBreast™ Acquires Molecular Breast Imaging Assets from Dilon Technologies® News provided by Share this article PITTSBURGH, Dec. 29, 2020 /PRNewswire/ -- Smart Breast Corporation (SmartBreast™), a privately held company focused on breast cancer screening and detection, announced today that it has acquired certain Molecular Breast Imaging (MBI) assets from Dilon Technologies, Inc. (Dilon) for an undisclosed amount. Dilon D6800 MBI scanner acquired by SmartBreast. Comparison of mammogr...
Source: prnewswire.com